Pacira BioSciences Inc (NASDAQ:PCRX) currently has a daily average trading volume of 883.79K but it saw 333715 shares traded in last market. With a market cap of 1.12B USD, the company’s current market price of $24.15 came falling about -0.98 while comparing to the previous closing price of $24.39. In past 52 weeks, the stock remained buoying in the range of price level as high as $29.61 and as low as $11.16. In the recent trading on the day, stock has struck highest price mark of $24.09 while lowest mark touched by it was $24.67.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Truist which upgraded the stock as “Hold” in its note to investors issued on January 30, 2025, recommending a price target of between $8 and $25 for it. Truist downgraded its recommendation for the stock as a “Sell” from “Buy” on August 13, 2024 while assigning a price target range of $30-$8. RBC Capital Mkts issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $37 and $14.
Over the week, PCRX’s stock price is moving -0.78% down while it is -7.65% when we observe its performance for the past one month. Year-to-date it is 28.18% up and over the past year, the stock is showing a downside performance of -14.15%.
Currently, Pacira BioSciences Inc’s total number of outstanding shares is 46.28M. Company’s return on investment (ROI) stands at -8.48% and return on equity (ROE) at -12.27%. It has a 7.05 of forward P/E ratio. Stock’s beta reads 0.51. Stock has a price to book (P/B) ratio of 1.40 while price to sale or P/S ratio amounts to 1.59. Its return on asset (ROA) is -6.54% on average.
